India Increases Supply of National Protocol Drugs Including Ivermectin with Apparent Results While Talk of Dropping Remdesivir

India Increases Supply of National Protocol Drugs Including Ivermectin with Apparent Results While Talk of Dropping Remdesivir

The Indian government, health authorities, companies, and elements within civil society continue to battle this most severe wave of the COVID-19 pandemic, powered by a virulent variant spread by migrant workers fleeing lockdowns as TrialSite reported on May 8. Since then, TrialSite reports that the government's efforts to ensure an adequate supply of therapies listed on the nation’s national protocol intensifies while one notable drug may be dropped. Apparently, India’s authorized a five-fold increase in ivermectin production from 15 million 12 mg tablets in April to 77 million tablets in May. While the government actually claimed it’s also ramped up Remdesivir production by 10 times (1 million vials in April to 10 million vials in May), some material chatter in India’s press suggests that the Indian Council of Medical Research (ICMR) could drop Remdesivir from its nationwide COVID-19 protocol. Experts are apparently questioning the antiviral drug’s efficacy much like the World Health Organization has due to the results in the Solidarity study. The population-wide Ivermectin-based treatment protocol in Uttar Pradesh corresponds with a dramatic reduction in new cases—is t...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee